Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
369.20    -0.60 (-0.16%)
Bid:
369.40
Ask:
369.80
Spread: 0.40 (0.108%)
Market Cap: £1.96b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Hammerson Completes Refinancing Transactions

9 Oct 2024 07:00

RNS Number : 4219H
Hammerson PLC
09 October 2024
 

9 October 2024

Hammerson plc

("Hammerson" or the "Company/Group")

Hammerson completes refinancing transactions to underpin growth strategy

Following the successful issuance of its 12-year £400m bond, Hammerson sets out the final outcome of the new issuance and accompanying tender of the Company's outstanding bonds maturing in 2026 and 2028:

· 12-year £400m bond pricing confirmed on 3 October at a coupon of 5.875% representing a spread of 183 basis points over the reference gilt rate

· Strong demand led to peak order book in excess of £2.6bn (over 7x subscribed)

· The repurchase of a total of £411.6m bonds, comprising £168.4m of 6% 2026s and £243.2m of 7.25% 2028s

· An annualised net interest benefit to Hammerson of £3.6m1 per year (approximately £0.8m for the financial year ending 2024)

· This reduces weighted average gross interest from 3.8%2 to 3.6% and extends Hammerson's weighted average debt maturity from 2.9 years3 to 5.2 years

· The refinancing is largely leverage neutral; pro forma4 LTV at 30 June 2024 is 25.5% and net debt:EBITDA is 5.4x

 

Himanshu Raja, CFO of Hammerson plc, commented:

"The combined effect of our new £400m 5.875% bond maturing in 2036 and the tender of our existing short-dated sterling maturities reduces our ongoing interest costs and extends our weighted average debt maturity. The strong demand and competitive pricing are a clear recognition from investors of the strength of our portfolio, the robust balance sheet and the opportunity ahead of us."

 

1 Annualised interest benefit arises due to the weighted average interest cost on the bonds tendered (6% on 2026s and 7.87% on 2028s) being 7.1% and higher than the 5.875% coupon on the new issue, offset by the impact of new issue discounts and the reduction to interest receivable due to net cash outflows.

2 Weighted average gross interest rate at 30 June 2024 of 3.4% and pro forma for the refinancing of Dundrum in August 2024 of 3.8%.

3 Weighted average debt maturity at 30 June 2024 of 2.2 years and pro forma for the refinancing of Dundrum in August 2024 of 2.9 years. 

4 Pro forma for the tender and new issuance financing transactions and the disposal of the Group's interest in Value Retail generating net proceeds of £583m. Pro forma at 30 June 2024 reflecting only the disposal of the Group's interest in Value Retail; LTV was 24.7% and net debt:EBITDA was 5.3x.

 

ENDS

Hammerson plc

Investor Contact

Josh Warren, Hammerson, Director of Strategy, Commercial Finance and Investor Relations

 

 

 

+44 (0)20 7887 1053

MHP for Hammerson Media

Oliver Hughes

Ollie Hoare

 

+44 (0)7885 224 532

+44 (0)7817 458 804

 

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZMGGKRNGDZM
Date   Source Headline
12th Jul 202112:15 pmRNSDirector Declaration
12th Jul 202112:00 pmRNSDirector/PDMR Shareholding - Replacement
9th Jul 202111:30 amRNSNotice of Results
9th Jul 20219:00 amRNSDirector/PDMR Shareholding
5th Jul 20213:30 pmRNSNotice of Redemption Price
2nd Jul 202110:45 amRNSHolding(s) in Company
28th Jun 202111:00 amRNSHolding(s) in Company
24th Jun 20213:00 pmRNSHolding(s) in Company
23rd Jun 202111:30 amRNSHolding(s) in Company
21st Jun 202111:00 amRNSDirector Declaration
16th Jun 202111:00 amRNSHolding(s) in Company
14th Jun 20214:30 pmRNSHolding(s) in Company
7th Jun 202112:15 pmRNSDirector/PDMR Shareholding
4th Jun 20215:31 pmBUSEarly Repurchase(s)
4th Jun 20215:29 pmBUSEarly Repurchase(s)
4th Jun 20217:00 amRNSNotice of Exercise of Call Option
1st Jun 20214:45 pmRNSFinal Results of Bond Tender Offer
1st Jun 202110:30 amRNSBond Tender Offer - Indicative Results
1st Jun 202110:00 amRNSBlock listing Interim Review
28th May 202111:30 amRNSHolding(s) in Company
27th May 202112:00 pmRNSBond Tender Offer Update
27th May 20217:00 amRNSSustainability-Linked Bond Launch
26th May 20219:30 amRNSHolding(s) in Company
21st May 20214:30 pmRNSHolding(s) in Company
20th May 20219:45 amRNSBond Tender Offers
19th May 20214:30 pmRNSNotification of Transactions of Directors/PDMRs
19th May 202112:45 pmRNSCompletion of retail parks portfolio disposal
13th May 20219:00 amRNSTotal Voting Rights
10th May 20217:00 amRNSFinal Dividend and Enhanced Scrip Alternative
4th May 202112:28 pmRNSResult of AGM
27th Apr 20213:30 pmRNSDirector/PDMR Shareholding
21st Apr 20211:15 pmRNSDisposal
21st Apr 20219:30 amRNSHolding(s) in Company
20th Apr 20217:00 amRNSDirectorate Change
20th Apr 20217:00 amRNSOperational and Rent Collection Update
19th Apr 20214:30 pmRNSDirector/PDMR Shareholding
15th Apr 20212:00 pmRNSHolding(s) in Company
15th Apr 20219:30 amRNSHolding(s) in Company
13th Apr 202112:15 pmRNSHolding(s) in Company
13th Apr 202111:30 amRNSHolding(s) in Company
12th Apr 20212:00 pmRNSHolding(s) in Company
12th Apr 20217:00 amRNSResponse to Press Speculation
8th Apr 20219:00 amRNSVirtual Shareholder Engagement Session
1st Apr 202110:20 amRNSHolding(s) in Company
1st Apr 202110:00 amRNSDirector/PDMR Shareholding
1st Apr 20219:45 amRNSCash Fractions for the Enhanced Scrip Dividend
31st Mar 20212:00 pmRNSDirector/PDMR Shareholding
29th Mar 202111:00 amRNSAnnual Report, Notice of AGM & Scrip Circular
29th Mar 20219:30 amRNSHolding(s) in Company
24th Mar 20213:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.